Predictors of medication adherence in an urban latino community with healthcare disparities

Journal of Immigrant and Minority Health

Volumn 14, Issue 4, 2012, Pages 589-595

  Colby, Jennifer A ^a   Wang, Fei ^b   Chhabra, Jyoti ^c   Pérez Escamilla, Rafael ^d  

^a INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c HARTFORD HOSPITAL   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Compliance; Diabetes; Hispanic; Latino; Medication adherence; Nonadherence

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; CULTURAL COMPETENCE; DIABETES MELLITUS; ETHNOLOGY; FEMALE; FORECASTING; GLUCOSE BLOOD LEVEL; HEALTH CARE DISPARITY; HISPANIC; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; UNITED STATES;

BLOOD GLUCOSE; CONNECTICUT; CROSS-SECTIONAL STUDIES; CULTURAL COMPETENCY; DIABETES MELLITUS; FEMALE; FORECASTING; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84865862977     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-011-9545-7     Document Type: Article

References (55)

1. National Institute of Diabetes and Digestive and Kidney Disease. National Diabetes Statistics, 2007 fact sheet. Bethesda MD: U.S. Department of Health and Human Services, National Institutes of Health, 2008. Available at http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm. Accessed 23 July 2010
2. U.S. Census Bureau. Projected population of the United States, by race and Hispanic origin: 2000 to 2050. Available at www.census.gov/ipc/www/ usinterimproj/. Accessed 23 July 2010
3. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-65
4. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-72
5. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2009;359(15):1577-89
6. Brown AF, Gerzoff RB, Karter AJ, et al. Health behaviors and quality of care among Latinos with diabetes in managed care. Am J Pub Health. 2003;93(10):1694-8
7. Gossec L, Tubach F, Dougados M, et al. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: A systematic literature review. Am J Med Sci. 2007;334(4):248-54
8. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015-21
9. Krapek K, King K, Warren SS, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38(9):1357-62
10. Heisler M, Smith DM, Hayward RA, et al. How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services? Diabetes Care. 2003;26(3):738-43
11. Pladevall M, Williams LK, Potts LA, et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800-5
12. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41
13. Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74-109
14. Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes. Diabetes Care. 2007;30(9):2222-7
15. Mateo JF, Gil-Guille'n VF, Mateo E, et al. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Int J Clin Pract. 2006;60(4):422-8
16. Walker EA, Molitch M, Kramer MK, et al. Adherence to preventive medications. Diabetes Care. 2006;29(9):1997-2002
17. Venturini F, Nichol MB, Sung JCY, et al. Compliance with sulfonylureas in a health maintenance organization: A pharmacy record-based study. Ann Pharmacother. 1999;33(3):281-8
18. 2010 National healthcare disparities report. Rockville, MD: AHRQ, Feb 2011. AHRQ publication no. 11-0005. Available at www.ahrq.gov/qual/qrdr10.htm. Accessed on 19 April 2011
19. Perez-Escamilla R, Vega-Lo'pez S, Damio G, et al. Short and long term impacts of diabetes peer counseling on HbA1c among Latinos: Preliminary results, Faseb J 2009; 23 336-338
20. Perez-Escamilla R, Vega-Lo'pez S, Damio G et al. Short and long term impacts of diabetes peer counseling on HbA1c among Latinos: Preliminary results. Faseb J. 2009; 23:336.8. Abstract. 20. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74
21. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother. 2004;38(9):1363-8
22. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30
23. Stuart BC, Simoni-Wastila L, Zhao L, et al. Increased persistency in medication use by U.S. medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647-9
24. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study. Clin Ther. 2003;25(11):2958-71
25. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther. 1998;20(4):764-71
26. Mann DM, Ponieman D, Leventhal H, et al. Predictors of adherence to diabetes medications: The role of disease and medication beliefs. J Behav Med. 2009;32(3):278-84
27. Vanderpoel DR, Hussein MA, Watson-Heidari T, et al. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysis. Clin Ther. 2004;26(12):2066-75
28. Thayer S, Arondekar B, Harley C, et al. Adherence to a fixeddose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea. Ann Pharmacother. 2010;44(5): 791-9
29. Bailey CJ, Day C. Fixed-dose single tablet antidiabetic combinations. Diabetes Obes Metabol. 2009;11(6):527-33
30. Grant RW, Devha NG, Singer DE, et al. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408-12
31. Melikian C, White TJ, Vanderplas A, et al. Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther. 2002;24(3):460-7
32. Colombi AM, Yu-Isenberg K, Priest J. The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization. J Occup Environ Med. 2008;50(5):535-41
33. Barron J, Wahl P, Fisher M et al. Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications. P&T 2008; 33(9):532-40,553
34. Tseng C-W, Tierney EF, Gerzoff RB, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes. Diabetes Care. 2008;31(2):261-6
35. Piette JD, Wagner TH, Potter MB, et al. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42(2):102-9
36. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: A review of the literature. J Gen Intern Med. 2007;22(6):864-71
37. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34(4): 692-7
38. Granger BB, Ekman I, Granger CB, et al. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009;11(11):1092-8
39. Mann DM, Allegrante JP, Natarajan S, et al. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther. 2007;21(4):311-6
40. Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48(3): 196-202
41. Ndumele CD, Shaykevich S, Williams D. Disparities in adherence to hypertensive care in urban ambulatory settings. J Health Care Poor Underserved. 2010;21(1):132-43
42. Berry LL, Parish JT, Janakiraman R, et al. Patients' commitment to their primary physician and why it matters. Ann Fam Med. 2008;6(1):6-13
43. Fuertes Jn, Mislowack A, Bennett J et al. The physician-patient working alliance. Patient Educ Couns 2007; 66(1):29-36
44. Schousboe JT, Davison ML, Dowd B, et al. Predictors of patients' perceived need for medication to prevent fracture. Med Care. 2011;49(3):273-80
45. Martin MY, Kohler C, Kim YI, et al. Taking less than prescribed: medication nonadherence and provider-patient relationships in lower income, rural minority adults with hypertension. J Clin Hypertens. 2010;12(9):706-13
46. Donohue JM, Huskamp HA, Wilson IB, et al. Whom do older adults trust most to provide information about prescription drugs? Am J Geriatr Pharmacother. 2009;7(2):105-16
47. Bender B. Physician-patient communication as a tool that can change adherence. Ann Allergy Asthma Immunol. 2009;103(1):1-2
48. Ledford CJW, Villagran MM, Kreps GL, et al. "Practicing medicine": Patient perceptions of physician communication and the process of prescription. Patient Educ Couns. 2010;80(3):384-92
49. Richard C, Lussier MT. Nature and frequency of exchanges on medications during primary care encounters. Patient Educ Couns. 2006;64:207-16
50. Stavropoulou C. Non-Adherence to medication and doctor-patient relationship: Evidence from a European survey. Patient Educ Couns. 2011;83(1):7-13
51. Alazri MH, Neal RD. The association between satisfaction with services provided in primary care and outcomes in type 2 diabetes mellitus. Diabet Med. 2003;20(6):486-90
52. Bonds DE, Camacho F, Bell RA et al. The association of patient trust and self-care among patients with diabetes mellitus. BMC Fam Pract 2004; 5:Part.no.26
53. Rosland A-M, Kieffer E, Israel B, et al. When is social support important? The association of family support and professional support with specific diabetes self-management behaviors. J Gen Intern Med. 2008;23(12):1992-9
54. Ciechanowski PS, Katon WJ, Russo JE, et al. The patient-provider relationship: Attachment theory and adherence to treatment in diabetes. Am J Psychiatry. 2001;158(1):29-35
55. Parchman ML, Flannagan D, Ferrer RL, et al. Communication competence, self-care behaviors and glucose control in patients with type 2 diabetes. Patient Educ Counsel. 2009;77(1):55-9.